Machine learning for nocturnal diagnosis of chronic obstructive pulmonary disease using digital oximetry biomarkers

TL;DR

This study demonstrates that nocturnal oximetry time series can be used to diagnose COPD, revealing unique digital biomarkers and offering a non-invasive screening method for at-risk populations.

Contribution

First to evaluate the feasibility of COPD diagnosis from nocturnal oximetry data using machine learning in a sleep-disordered breathing population.

Findings

Digital oximetry biomarkers effectively distinguish COPD patients.

Random forest classifier achieves promising diagnostic performance.

Overnight oximetry provides a non-invasive COPD screening pathway.

Abstract

Objective: Chronic obstructive pulmonary disease (COPD) is a highly prevalent chronic condition. COPD is a major source of morbidity, mortality and healthcare costs. Spirometry is the gold standard test for a definitive diagnosis and severity grading of COPD. However, a large proportion of individuals with COPD are undiagnosed and untreated. Given the high prevalence of COPD and its clinical importance, it is critical to develop new algorithms to identify undiagnosed COPD, especially in specific groups at risk, such as those with sleep disorder breathing. To our knowledge, no research has looked at the feasibility of COPD diagnosis from the nocturnal oximetry time series. Approach: We hypothesize that patients with COPD will exert certain patterns and/or dynamics of their overnight oximetry time series that are unique to this condition. We introduce a novel approach to nocturnal COPD diagnosis using 44 oximetry digital biomarkers and 5 demographic features and assess its performance in a population sample at risk of sleep-disordered breathing. A total of n=350 unique patients polysomnography (PSG) recordings. A random forest (RF) classifier is trained using these features and evaluated using the nested cross-validation procedure. Significance: Our research makes a number of novel scientific contributions. First, we demonstrated for the first time, the feasibility of COPD diagnosis from nocturnal oximetry time series in a population sample at risk of sleep disordered breathing. We highlighted what digital oximetry biomarkers best reflect how COPD manifests overnight. The results motivate that overnight single channel oximetry is a valuable pathway for COPD diagnosis.